Business EconomyPosted at: Jun 8 2026 5:15PM


Viyash Scientific to acquire Italy’s BioForLife for Rs ₹188 Cr Strengthening Global Pet Care Business

Hyderabad, June 8 (UNI) Hyderabad-based Viyash Scientific Limited, through its wholly owned subsidiary Alivira Animal Health Limited, has signed a binding agreement to acquire a 100 per cent stake in BioForLife (BFL), a leading pet care company headquartered in Milan.
The acquisition, valued at Rs ₹188 crore in cash, is expected to be completed during the second quarter of FY27, the company announced today.
The transaction marks a significant milestone in Viyash Scientific’s strategy to expand its footprint in the rapidly growing global Companion Animal Health Generics market.
The acquisition will strengthen Alivira’s companion animal health business globally and enhance its presence in the European pet care sector.
Italy is among Europe’s five largest animal health markets, with companion animal care emerging as one of its fastest-growing segments, driven by increasing pet ownership, pet humanisation trends and higher spending on preventive and specialised veterinary care.
BioForLife specializes in the development, commercialization and distribution of pet care products.
The company has built a strong portfolio spanning nutritional supplements, pharmaceuticals and rapid diagnostic tests, while also expanding into high-growth segments such as dermatology and ophthalmology.
With an established sales network reaching more than 80 per cent of veterinary clinics across Italy, BioForLife provides strong market access and customer relationships that are expected to support future growth initiatives.
The acquisition will provide Viyash Scientific, headquartered in Jubilee Hills, with a platform to introduce products from Alivira’s development pipeline into the Italian market.
At the same time, it will create opportunities to expand BioForLife’s product range across Alivira’s operations in Europe, the Middle East, Asia and Latin America.
Commenting on the development, Dr. Haribabu Bodeputi, Managing Director and Group CEO of Viyash Scientific Limited, said the acquisition is an important step toward building a leading global companion animal health business.
He noted that BioForLife offers an established platform in one of Europe’s most attractive pet care markets and strengthens the company’s regional presence. According to him, combining BioForLife’s commercial reach with Alivira’s product development capabilities will help accelerate growth, broaden the companion animal health portfolio and create greater value for veterinarians, pet owners and business partners.
Dr. Bodeputi also said the company sees significant opportunities to introduce innovative products into India and other international markets through its global network, adding that the investment reflects Viyash Scientific’s commitment to sustainable growth, strategic expansion and long-term value creation.
The acquisition will also strengthen Alivira’s leadership team, with BioForLife’s existing executives expected to continue managing business operations while driving new growth initiatives.
The transaction builds on Alivira’s track record of international expansion, having successfully acquired and integrated multiple animal health companies across Europe, Latin America and Asia over the past decade.
UNI KNR SS
Please log in to get detailed story.
Tags: #Viyash Scientific to acquire Italy’s BioForLife for Rs ₹188 Cr Strengthening Global Pet Care Business
More News

Industrial and warehousing leasing rises 12pc to 22 million sqft; Delhi NCR, Chennai lead: Report

16 Jul 2026 | 6:33 PM

New Delhi, Jul 16 (UNI) India's industrial and warehousing real estate market maintained strong momentum during the first half of 2026, with Grade A leasing rising 12pc year-on-year (Y-o-Y) to nearly 22 million square feet across the country's top eight cities, despite global geopolitical uncertainties impacting supply chains.

see more..

NSE to launch derivatives on Nifty India FPI 150 Index

16 Jul 2026 | 5:35 PM

Mumbai, Jul 16 (UNI) The National Stock Exchange (NSE) officially announced here on Thursday that it has received approval from the Securities and Exchange Board of India (SEBI) to introduce derivatives on the Nifty India FPI 150 Index, expanding its equity derivatives product suite, which would offer foreign portfolio investors (FPIs) another benchmark-linked hedging instrument.

see more..

Stock markets fail to hold early gains, weigh down by weak global cues

16 Jul 2026 | 5:21 PM

New Delhi, Jul 16 (UNI) The Indian Stock Markets on Thursday failed to hold on to their early gains and ended flat in a volatile session. Indices were weighed down by weak global cues and profit booking.

see more..

Crisil FCI Index improves in June on easing US-Iran tensions, stronger rupee and favourable FPI Inflows

16 Jul 2026 | 4:24 PM

New Delhi, Jul 16 (UNI) Crisil’s Financial Condition Index (FCI) rose to - (negative)0.2 in June from - (negative)1.2 in May after remaining below the comfort band of one standard deviation from the long-period average for three months due to easing geopolitical situation, slight strengthening of the Rupee, and favourable FPIs, said the monthly Macroeconomics First Cut.

see more..

India to see slower growth in 2026 amid global headwinds: Moody's Analytics

16 Jul 2026 | 3:56 PM

New Delhi, Jul 16 (UNI) India's economy is expected to moderate this year as escalating geopolitical tensions, softer global demand and persistent trade uncertainties weigh on economic activity, according to Moody's Analytics.

see more..